Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Advances in Radiation Oncology|June 1, 2022
Radiomic Modeling of Bone Density and Rib Fracture Risk After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung CancerNicholas R Rydzewski, Poonam Yadav, Hima Bindu Musunuru, et al.JCO Precision Oncology|September 26, 2025
Immune and Genomic Heterogeneity of MET-Altered Non-Small Cell Lung CancerManlu Liu, Rachel L Minne, Saahil Javeri, et al.International Journal of Clinical Oncology|March 13, 2013
A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancerJiayi Huang, Andrew M Baschnagel, Peter Chen, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 22, 2016
Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomasAndrew M Baschnagel, Nathan Tonlaar, Mohammad Eskandari, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung CancerShrey Ramesh, Ahmet Cifci, Saahil Javeri, et al.Metabolites|May 27, 2025
Characterizing Plasma-Based Metabolomic Signatures for Metastasis in Non-Small Cell Lung CancerManlu Liu, Yanlong Zhu, Sean J McIlwain, et al.Advances in Radiation Oncology|October 21, 2020
Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation TherapyAdam R Burr, Henry Ian Robins, Robert Adam Bayliss, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2014
c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiationAndrew M Baschnagel, Lindsay Williams, Alaa Hanna, et al.International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung CancerShrey Ramesh, Ahmet Cifci, Saahil Javeri, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2015
The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomasAndrew M Baschnagel, Jessica L Wobb, Joshua T Dilworth, et al.Pageof 7